ABOUT US

PharmAsia-Cuvest, Inc. is a dynamic Philippine pharmaceutical company operating nation-wide, with an average growth of 14.5% annually from 2009 to 2013. We represent laboratories in Europe, Israel and Asia manufacturing high quality off-patent and cost-effective drugs for Infectious Diseases, Psychiatry, Neurology, Obstetrics and Gynecology, Infertility, Cardiology, Oncology, and Urology.

Our products are found in practically all major hospitals and drugstores, available to millions of Filipinos throughout the country.

Several of our products for Infectious Diseases and Psychiatry are among the top 5 brands in their categories. Seeking to expand on that success, we continually seek in-licensing opportunities and new collaborative relations with companies around the world. Please contact us for more details.

HISTORY

The company was originally incorporated as Cuvest Pharmaceuticals. From its inception in 1950, Cuvest specialized in the marketing and distribution of finished pharmaceutical and biological products. Among its first principals were Wyeth Laboratories, Armour Pharmaceuticals, Institut Merieux, and Institut Pasteur. All have since assumed domestic marketing and distribution of their respective products after Cuvest's trailblazing efforts to make their products market leaders. The later principals represented were Bausch & Lomb (USA), Dexxon (Israel), Egis (Hungary), Gedeon Richter (Hungary) and Solco (Switzerland).

In 1988, a second company called PharmAsia, Inc. was formed specifically to market to hospitals and the government sector. It had its own field force and office staff. The companies it represented were Astrapin (Germany) and Stada (Germany).

At the end of 2000 the Board of Directors decided to merge Cuvest and PharmAsia. Both companies stood to benefit from improved operational efficiency, as well as complementation in marketing activities. Thus, in January of 2001, a new company called PharmAsia-Cuvest, Inc. was formed out of the merger.

Today, PharmAsia-Cuvest, Inc. continues to represent and distribute high quality off-patent pharmaceuticals manufactured by its principals in Europe and Asia. We are committed to continue working with foreign and local pharmaceutical companies in bringing relevant, excellent and cost-effective medicines to the Filipino people.